01 January 2002
Pain management considerations for surgical oncological
patients
Eliad E. Aviram , Avi A. Weinbroum
Case Rep Clin Pract Rev 2002; 3(3):181-186 :: ID: 474514
Abstract
The unique perioperative considerations in anesthetizing surgical-oncological patients have not received much attention, nor has the nature of the roles of the specialists who make up the team that accommodates their special
needs been precisely defined. The pathophysiological conditions of these patients are characterized by organ(s) malfunction, partly iatrogenically-induced, for which the skill that is requested from the team that handles
these cases is high. This regards the preparation of the patients both physically and mentally, the evaluation of extensive information and its impact on the surgical decision-making, the possible large number of specialists
whose opinion is requested at any stage of the treatment as well as the quality of the dedicated team that will follow the patient form the time he/she wakes up postoperatively through rehabilitation process to the moment
in which the patient is informed, several years later, that he is cured, or, less fortunately, that an additional operation is required to remove a recurrence. Undoubtedly, an essential factor that would ease the decision-makers
communicate with the patient and the family is proper and satisfactory pain control. This would allow peace of mind to the patient and careful judgment in his/her regards. This paper addresses these issues, mainly form the authors’ prospective and presents brief guidelines for optimal pain management for patients undergoing surgery for malignant conditions.
Keywords: Malignancy, antinociception, perioperative, Pain
441
In Press
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.949976
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.950290
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.950607
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.950985
Most Viewed Current Articles
07 Dec 2021 : Case report
17,691,734
DOI :10.12659/AJCR.934347
Am J Case Rep 2021; 22:e934347
06 Dec 2021 : Case report
164,491
DOI :10.12659/AJCR.934406
Am J Case Rep 2021; 22:e934406
21 Jun 2024 : Case report
113,090
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
07 Mar 2024 : Case report
59,175
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133






